期刊文献+

miR-218和miR-152在浆液性卵巢癌的表达及临床意义 被引量:3

Expression of miR-218 and miR-152 in serous ovarian cancer and its clinical significance
在线阅读 下载PDF
导出
摘要 目的检测miR-218和miR-152在浆液性卵巢癌中的表达情况,并探讨其临床意义。方法取正常输卵管伞端上皮组织、良性病变卵巢组织以及浆液性卵巢癌组织,应用Real-time PCR技术检测miR-218和miR-152在上述组织中的表达情况,分析其表达与卵巢癌临床病理特征之间的关系。结果 Real-time PCR检测显示,卵巢癌组织中miR-218和miR-152的表达(分别为404.5和382.9)显著低于正常输卵管伞端上皮组织(分别为598.7和678.4)和良性病变组织(分别为523.3和587.3)(P<0.05);miR-218的低表达与卵巢癌恶性程度、肿瘤分化程度以及肿瘤转移情况相关(P<0.05),而miR-152的表达与浆液性卵巢癌各临床病理特征无显著相关性(P>0.05)。结论 miR-218和miR-152在浆液性卵巢癌组织中低表达,miR-218有可能成为浆液性卵巢癌诊断和预后的标志物。 Objective: To investigate the expression of miR-218 and miR-152 in serous ovarian cancer and its clinical significance. Methods: The expressions of miR-218 and miR-152 in the distal epithelial tissue of fallopian tube or ovarian tissue from 50 patients with serous ovarian cancer, 20 patients with benign ovarian epithelial tumors and 10 patients with normal ovarian tissues were detected by Stem-loop real-time PCR. The correlation between the expression of miR-218 ~ miR-152 and clinieopathologic features were further analyzed. Results: The expression of miR-218 and miR-152(404.5 and 382.9)was significantly lower in serous ovarian cancer tissue than that in the distal epithelial tissue of normal fallopian tube(598.7 and 678.4)or the benign ovarian tumors tissue(523.3 and 587.3)(P〈0.05). The expression of miR-218 in serous ovarian cancer was closely related to ovarian cancer malignant degree, tumor differentiation degree and tumor metastasis status (P〈0.05). However, the expression of miR-152 was not correlated with the elinicopathologic features of serous ovarian cancer(P〉0.05). Conclusions: The expression of miR-218 and miR-152 in serous ovarian cancer is lower. The miR-218 might be potential marker for serous ovarian cancer.
出处 《生殖医学杂志》 CAS 2015年第4期293-296,共4页 Journal of Reproductive Medicine
关键词 浆液性卵巢癌 微小RNA MIR-218 miR-152 Serous ovarian cancer microRNA miR-218 miR-152
作者简介 赵立红,女,河北廊坊人,本科,主治医师,妇产科专业.Email:lihong_zhaolf@126.com
  • 相关文献

参考文献23

  • 1Syrios J, Banerjee S, Kaye SB. Advanced epithelial ovarian cancer:from standard chemotherapy to promising molecular pathway targets-where are we now? [J]. Anticancer Res, 2014,34:2069-2077.
  • 2Marsh DJ ,Shah JS,Cole AJ. Histories and their modifications in ovarian cancer-drivers of disease and therapeutic targets [J]. Front Oneol, 2014,4 : 144.
  • 3Bartels CL,Tsongalis GJ. MicroRNAs:novel biomarkers for human cancer[J]. Clin Chem, 2009,55 : 623-631.
  • 4Visone R,Croee CM. MiRNAs and cancer[J]. Am J Pathol, 2009,174:1131-1138.
  • 5Yamasaki T, Seki N, Yoshino H, et al. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway[J]. J Urol, 2013,190 : 1059-1068.
  • 6Zhao Y,Li Y, Wang L, et al. MicroRNA response elements- regulated TRAIL expression shows specific survival- suppressing activity on bladder cancer[J]. J gxp Clin Cancer Res,2013,32 : 10.
  • 7饶玉梅,纪妹,史惠蓉,陈彩虹.miR-218靶向Wnt2B抑制卵巢癌细胞转移侵袭功能[J].华中科技大学学报(医学版),2013,42(6):656-658. 被引量:6
  • 8Chen Y, Song Y, Wang Z. Altered expression of MiR-148aand MiR-152 in gastrointestinal cancers and its clinical significance[J]. J Gastrointest Surg, 2010,14 : 1170-1179.
  • 9娄艳辉,杨兴升,王福玲,钱金花,黄煜.miR-21在上皮性卵巢癌组织中的表达及临床意义[J].南方医科大学学报,2010,30(3):608-610. 被引量:14
  • 10Tsuruta T, Kozaki K, Uesugi A, et al. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer [J]. Cancer Res, 2011,71 : 6450-6462.

二级参考文献60

  • 1lorio MY, Fcrracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer[J]. Cancer Res, 2005, 65(16): 7065-70.
  • 2Chan JA, Kriehevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotie factor in human glioblastoma cells[J]. Cancer Bes, 2005, 65 (14): 6029-33.
  • 3Hede IC Studies define role ofmicroRNA in cancer[J]. J Natl Cancer Inst, 2005, 97(15): 1114 -5.
  • 4Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer [J]. Cancer Res, 2005, 65(9): 3509-12.
  • 5Lui WO, Pourmand N, Patterson BK, et al. Patterns of known and novel small RNAs in human cervical cancer[J]. Cancer Res, 2007, 67(13): 6031-43.
  • 6Narn E J, Yoon H, Kim SW, et al. MicroRNA expression profiles in serous ovarian carcinoma[J].Clin Cancer Res, 2008, 14(9): 2690-5.
  • 7Iorio MV, Visone R, Di Leva G, et al. MicroRNA signatures in human ovarian cancer[J]. Cancer Res, 2007, 67(18): 8699-707.
  • 8Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-2 1 regulates expression of the PTEN tumor suppressor gene in human hepatoeellular cancer[J]. Gastroenterology, 2007, 133(2): 647-58.
  • 9Li AJ, Karlan BY. Genetic factors in ovarian carcinoma [J]. Curr Oncon Rep, 2001, 3(1): 27-32.
  • 10Chen CZ, Li L, Lodish I-IF; et al. MicroRNAs modulate hematopoietic lineage differentiation. Science, 2004,303(5654): 83-86.

共引文献34

同被引文献9

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部